Boston Scientific Acquires Devoro Medical
September 21, 2021
Boston Scientific agreed to acquire the remaining 84% of Devoro Medical, developer of the WOLF Thrombectomy Platform, paying approximately $269 million upfront plus up to $67 million in milestone payments. Boston Scientific had been a strategic investor in Devoro since 2019 (holding ~16%); the acquisition expands Boston Scientific’s clot-management and peripheral interventions product portfolio by adding a non-console, lytic-free thrombectomy technology.
- Buyers
- Boston Scientific Corporation
- Targets
- Devoro Medical, Inc.
- Industry
- Medical Devices
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
SARIA Acquires Devro for £540 Million
November 27, 2022
Food & Beverage
SARIA SE & Co. KG has agreed to acquire Scotland-based collagen casing maker Devro for £540 million. The purchase will combine SARIA’s existing casing activities with Devro’s global manufacturing footprint to broaden product offerings, increase scale and accelerate long-term sustainable growth.
-
Surmodics Acquires Vetex Medical Limited
July 6, 2021
Medical Devices
Surmodics, Inc. (NASDAQ: SRDX) acquired Galway-based Vetex Medical Limited to expand its thrombectomy portfolio with the ReVene Thrombectomy Catheter. The deal included an upfront payment of $39.9 million and up to $7 million in additional milestone payments (with $3.5 million guaranteed), giving Surmodics a second FDA 510(k)-cleared mechanical thrombectomy device and IP to accelerate its thrombectomy platform development.
-
Boston Scientific Acquires Valencia Technologies
January 12, 2026
Medical Devices
On January 12, 2026, Boston Scientific acquired Valencia Technologies, the developer of the eCoin System — a coin-sized subcutaneous neuromodulation device for hypertension. The acquisition expands Boston Scientific's neuromodulation and cardiovascular device portfolio by adding a novel, minimally invasive therapy and provides Valencia access to Boston Scientific's regulatory, distribution, and commercialization resources.
-
Hologic Acquires Bolder Surgical for $160 Million
October 14, 2021
Medical Devices
Hologic, Inc. agreed to acquire Bolder Surgical, a Colorado-based developer of advanced energy vessel sealing and dissection devices, for approximately $160 million and has completed the previously announced transaction. The acquisition adds laparoscopic vessel sealing, dividing and dissecting devices (including pediatric-focused 3 mm and 5 mm tools) to Hologic’s Surgical portfolio, enabling capability expansion and broader commercialization into OB/GYN and hospital markets; Bolder was expected to generate about $10 million of product revenue in the calendar year.
-
Boston Scientific Acquires BTG plc
August 19, 2019
Medical Devices
Boston Scientific Corporation completed its acquisition of BTG plc by scheme of arrangement, with BTG shareholders receiving 840 pence in cash per share. The purchase brings BTG’s interventional medicine portfolio, specialty pharmaceuticals and licensing business into Boston Scientific, strengthening its capabilities in interventional oncology and vascular therapies.
-
Verge Medical Acquires RoVo System from 2MG Medical
June 30, 2025
Medical Devices
Verge Medical, a privately held medical technology company based in Campbell, California, acquired the RoVo System and its patented Temporary Occlusion Embolectomy (TOE) technology from 2MG Medical. The asset purchase (with FDA-cleared technology) expands Verge's portfolio of targeted vascular devices to address distal embolization risk during peripheral and coronary interventions.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.